You are currently viewing a new version of our website. To view the old version click .

Cancers, Volume 11, Issue 2

February 2019 - 144 articles

Cover Story: Tumour hypoxia is a feature of solid tumours that contributes to poor prognosis after treatment, due to increased resistance of hypoxic cells to radio- and chemotherapy, and increased metastasis incidence. The extent of hypoxia within a tumour is influenced by the tolerance of individual tumour cells to hypoxia, a feature that differs considerably between tumours. High numbers of hypoxic cells are a direct consequence of enhanced cellular capability to activate HIF-1α signalling, the unfolded protein response (UPR) and autophagy. Recent evidence indicates that hypoxia tolerance can be modulated by distant cells that have experienced hypoxia, and is mediated by the systemic release of factors, such as extracellular vesicles (EV) that can alter HIF-1α-, UPR-, angiogenesis- and autophagy signalling. View this paper
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (144)

  • Article
  • Open Access
22 Citations
4,654 Views
10 Pages

Preoperative Imaging Evaluation after Downstaging of Pancreatic Ductal Adenocarcinoma: A Multi-Center Study

  • Alessandro Beleù,
  • Angela Calabrese,
  • Giulio Rizzo,
  • Paola Capelli,
  • Nicolò Bellini,
  • Simona Caloggero,
  • Roberto Calbi,
  • Paolo Tinazzi Martini,
  • Riccardo De Robertis and
  • Giovanni Carbognin
  • + 5 authors

25 February 2019

Introduction: Evaluation of pancreatic ductal adenocarcinoma (PDAC) after chemoradiotherapy downstaging is challenging due to computed tomography (CT) overestimation of tumor extension and residual vascular involvement, limiting access to surgery to...

  • Review
  • Open Access
47 Citations
6,511 Views
12 Pages

Targeted Radionuclide Therapy: New Advances for Improvement of Patient Management and Response

  • Javian Malcolm,
  • Nadia Falzone,
  • Boon Q. Lee and
  • Katherine A. Vallis

25 February 2019

Compared to external beam radiotherapy, targeted radionuclide therapy (TRT) allows for systemic radiation treatment of metastatic lesions. Published work on recent strategies to improve patient management and response to TRT through individualising p...

  • Article
  • Open Access
15 Citations
4,418 Views
12 Pages

Selective Neck Dissection and Survival in Pathologically Node-Positive Oral Squamous Cell Carcinoma

  • Shunichi Shimura,
  • Kazuhiro Ogi,
  • Akihiro Miyazaki,
  • Shota Shimizu,
  • Takeshi Kaneko,
  • Tomoko Sonoda,
  • Junichi Kobayashi,
  • Tomohiro Igarashi,
  • Akira Miyakawa and
  • Tadashi Hasegawa
  • + 1 author

25 February 2019

The most important prognostic factor in oral squamous cell carcinoma (OSCC) is neck metastasis, which is treated by neck dissection. Although selective neck dissection (SND) is a useful tool for clinically node-negative OSCC, its efficacy for neck no...

  • Article
  • Open Access
28 Citations
5,945 Views
13 Pages

Developing a Prognostic Gene Panel of Epithelial Ovarian Cancer Patients by a Machine Learning Model

  • Tzu-Pin Lu,
  • Kuan-Ting Kuo,
  • Ching-Hsuan Chen,
  • Ming-Cheng Chang,
  • Hsiu-Ping Lin,
  • Yu-Hao Hu,
  • Ying-Cheng Chiang,
  • Wen-Fang Cheng and
  • Chi-An Chen

25 February 2019

Epithelial ovarian cancer patients usually relapse after primary management. We utilized the support vector machine algorithm to develop a model for the chemo-response using the Cancer Cell Line Encyclopedia (CCLE) and validated the model in The Canc...

  • Article
  • Open Access
29 Citations
9,484 Views
14 Pages

Identification of Novel HLA Class II-Restricted Neoantigens Derived from Driver Mutations

  • Susumu Iiizumi,
  • Junya Ohtake,
  • Naoko Murakami,
  • Taku Kouro,
  • Mamoru Kawahara,
  • Fumiko Isoda,
  • Hiroshi Hamana,
  • Hiroyuki Kishi,
  • Norihiro Nakamura and
  • Tetsuro Sasada

24 February 2019

Neoantigens derived from tumor-specific genetic mutations might be suitable targets for cancer immunotherapy because of their high immunogenicity. In the current study, we evaluated the immunogenicity of 10 driver mutations that are frequently expres...

  • Article
  • Open Access
17 Citations
4,574 Views
14 Pages

Loss of Stromal Galectin-1 Enhances Multiple Myeloma Development: Emphasis on a Role in Osteoclasts

  • Joséphine Muller,
  • Elodie Duray,
  • Margaux Lejeune,
  • Sophie Dubois,
  • Erwan Plougonven,
  • Angélique Léonard,
  • Paola Storti,
  • Nicola Giuliani,
  • Martine Cohen-Solal and
  • Ute Hempel
  • + 4 authors

23 February 2019

Multiple myeloma osteolytic disease is caused by an uncoupled bone-remodelling process with an increased osteoclast activity. Disease development relies on interactions between myeloma cells and bone marrow stromal cells. Recent findings suggest a ro...

  • Review
  • Open Access
22 Citations
5,441 Views
14 Pages

Circulating Tumor Cell Detection in Lung Cancer: But to What End?

  • Véronique Hofman,
  • Simon Heeke,
  • Charles-Hugo Marquette,
  • Marius Ilié and
  • Paul Hofman

23 February 2019

The understanding of the natural history and biology of lung cancer has been enhanced by studies into circulating tumor cells (CTCs). Fundamental and translational research, as well as clinical trials in the characterization and behavior of these cel...

  • Article
  • Open Access
21 Citations
5,154 Views
18 Pages

Deciphering the Mechanism of Action Involved in Enhanced Suicide Gene Colon Cancer Cell Killer Effect Mediated by Gef and Apoptin

  • Blanca Cáceres,
  • Alberto Ramirez,
  • Esmeralda Carrillo,
  • Gema Jimenez,
  • Carmen Griñán-Lisón,
  • Elena López-Ruiz,
  • Yaiza Jiménez-Martínez,
  • Juan A. Marchal and
  • Houria Boulaiz

23 February 2019

Despite the great advances in cancer treatment, colorectal cancer has emerged as the second highest cause of death from cancer worldwide. For this type of tumor, the use of suicide gene therapy could represent a novel therapy. We recently demonstrate...

  • Article
  • Open Access
1 Citations
3,992 Views
18 Pages

Integrative Omic Profiling Reveals Unique Hypoxia Induced Signatures in Gastric Cancer Associated Myofibroblasts

  • Hanna Najgebauer,
  • Andrew F. Jarnuczak,
  • Andrea Varro and
  • Christopher M. Sanderson

23 February 2019

Although hypoxia is known to contribute to several aspects of tumour progression, relatively little is known about the effects of hypoxia on cancer-associated myofibroblasts (CAMs), or the consequences that conditional changes in CAM function may hav...

  • Review
  • Open Access
62 Citations
10,149 Views
41 Pages

MicroRNA in Lung Cancer Metastasis

  • Shang-Gin Wu,
  • Tzu-Hua Chang,
  • Yi-Nan Liu and
  • Jin-Yuan Shih

23 February 2019

Tumor metastasis is a hallmark of cancer, with distant metastasis frequently developing in lung cancer, even at initial diagnosis, resulting in poor prognosis and high mortality. However, available biomarkers cannot reliably predict cancer spreading...

of 15

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Cancers - ISSN 2072-6694